Infectious Diseases – News and Features

The Company to start Phase 1 human safety study of its investigational eiRNA therapy for the treatment of chronic hepatitis B infection.

CLC Bio will work with two Danish research groups to design bioinformatic algorithms to study the molecular structure and evolution of certain viruses.

Under the deal, Proteome Systems will receive cash and the provision of Shimadzu’s latest mass spectrometer and protein separation technology.

National Genome Research Network has purchased Affymetrix’s Genome-Wide Human SNP Array 5.0 to genotype 17,000 individuals in a study of 25 diseases.

Scientists in Australia have begun experiments at the Australian Synchrotron located in Melbourne this week in preparation for the facility’s opening in July.

Sainsbury Laboratory scientists will lead an €11.8-million research consortium that will study the potential uses for RNA interference in treating disease.

The US FDA has cleared a Cepheid’s PCR test which is designed to detect nosocomial and antibiotic-resistant strain of Staphylococcus in over one hour.

Oklahoma Medical Research Foundation researchers have discovered a molecule that may lead to drug treatment for Alzheimer's disease.

MIGENIX will develop anti-infective disease therapies using GenomeQuest™'s 50 million patented sequences.

BioTrove’s high-throughput technology will enable the researchers to investigate human cellular response to chemical weapons and adult stem cell differentiation.